Altimmune (ALT) just closed a big $225M oversubscribed funding round in late April, giving the company a solid runway to push its lead drug pemvidutide into Phase 3 for MASH. With Q1 earnings coming up on May 13, the stock looks primed for a bounce back toward the $5–6 zone as the financing overhang clears and investors focus on the upcoming catalysts. Smart money (RA Capital, Viking, Deep Track, etc.) piled in for a reason — they see real potential in this dual-agonist for liver and metabolic diseases. Classic early-stage biotech setup: high risk, but the capital injection removes a major worry and sets up the next leg higher if the data delivers.” Short, straightforward, and realistic no hype, just the setup. 4k on May 15 2.5 C

---

not enough drug use in this sub. Wall Street my ass

---

My industry does random drug testing in addition to initial screening. Required by federal law.

---

Nice perspective. Do you drug test someone before you hire them? Been working at the same place for almost 9 years, never been drug tested. Never heard of it happening either. I'd be fine, just curious how this works these days.

---

This week I went on a business trip to Seattle to do some recruiting for my company. We are looking for Engineers. This young guy came up to me and said he has a CE degree, but no one will hire him. I said, "You wont know unless you try. I believe in you. But I gotta tell you, we do drug test. You're pale, sweating, and keep scratching your face, so... Let's not kid eachother."

---

It makes you feel slow? Like can you help me compare that to another drug Alcohol, marijuana?

---

From clinical to commercial in 1 day. ARVN breast cancer drug - VEPPANUgot approved by the FDA today🚀🚀🚀. Prolly minimum 500% banger by eoy.

---

Highly undervalued ARVN… breast cancer drug approved by FDA today. minimal debt. $685M cash and another $50M cash from Pfizer.🚀🚀🚀

---

I know alcoholics and drug addicts that behave more reasonable than this monstrosoty of a market.

---